13 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... medications #drugs #cardiology ... #warfarin #management
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
metabolization of DOACs thereby ... leading to lower ... metabolization leading ... inducers #inhibitors #Chemotherapy ... Interactions #Table #Pharmacology
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
Diagnosis and Management ... adrenoceptors, potentially leading ... pheochromocytoma: primary therapy ... pheochromocytoma: MIBG therapy ... palliative Treatment (chemotherapy
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Guideline-Directed Medical Therapy ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... disease, Cancer chemotherapy ... the mainstay of therapy ... Syndrome #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
framework to guide therapy ... need inotrope therapy ... differential #algorithm #management ... #cardiology #treatment ... icu #clinical #pharmacology
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
Anticoagulant Therapy ... with AFib) Dual-Therapy ... derick_gabel via ACCP Cardiology ... anticoagulation #PCI #pharmacology ... #management #cardiology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
disease): • Chemotherapy ... preferred first-line chemotherapy ... as adjunctive therapy ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed Medical Therapy ... Directed #Medical #Therapy ... GDMT #CKD #HFrEF #management ... #pharmacology # ... cardiology